MicroRNA microarray expression profiling in human myocardial infarction

Emanuela Bostjancic1, Nina Zidar, Damjan Glavac

  • 1Department of Molecular Genetics, Institute of Pathology, University of Ljubljana, Slovenia.

Disease Markers
|January 16, 2010
PubMed

Insights

This study reveals novel microRNA (miRNA) expression patterns in human myocardial infarction (MI), identifying key miRNAs potentially involved in cardiovascular disease progression and offering new diagnostic markers.

Area of Science:

  • Cardiovascular Biology
  • Molecular Genetics
  • Non-coding RNA Research

Background:

  • MicroRNAs (miRNAs) are small non-coding RNAs regulating gene expression and implicated in cardiovascular diseases.
  • Genome-wide miRNA expression patterns in human myocardial infarction (MI) remain largely uncharacterized despite numerous studies.

Purpose of the Study:

  • To investigate genome-wide miRNA expression profiles in human MI.
  • To compare miRNA expression in MI and fetal hearts versus healthy adult hearts.
  • To identify novel dysregulated miRNAs in cardiovascular disease.

Main Methods:

  • Utilized miRNA microarrays to analyze miRNA expression in human MI, fetal, and healthy adult hearts.
  • Employed bioinformatic analysis to identify dysregulated miRNAs and compare expression patterns.
  • Validated key miRNA dysregulations using quantitative reverse transcription PCR (qRT-PCR).

Main Results:

  • Approximately 50% of 719 analyzed miRNAs were expressed in human hearts; 57 were significantly dysregulated.
  • Identified similar miRNA expression patterns between MI and fetal hearts.
  • Discovered 10 novel miRNAs dysregulated in MI and 5 previously only described in animal models.
  • Confirmed dysregulation of 7 specific miRNAs (e.g., miR-1, miR-133a/b, miR-210) via qRT-PCR.

Conclusions:

  • MI exhibits distinct miRNA expression profiles, with similarities to fetal heart patterns.
  • Several novel miRNAs are dysregulated in MI, suggesting potential roles in cardiovascular pathology.
  • Identified miRNAs represent potential biomarkers for MI diagnosis and therapeutic targets.